ArticleBlood cancer journal2015

Prediction of response and survival in patients with chronic-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate: logistic regression and landmark analyses.

M Wetzler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.